Second Opinion: Liver Effects of CBD

Dr. Jeff Lombardo and Dr. Keith Aqua, both co-investigators of the Validcare study on observing potential liver effects in adults who are using a form of hemp-derived cannabidiol (CBD) for a minimum of 60 days, join Second Opinion to highlight key insights, including what prompted the study, preliminary results, their meeting with the FDA, and what’s next.